Trials / Completed
CompletedNCT02005926
The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph Nodes
Phase II Trail of Removing Sonographic Abnormal Lymph Node in Sentinel Lymph Node Biopsy of Breast Cancer Patient
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Tao OUYANG · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
* This is a phase II, prospective, single-center, non-randomized, non-controlled study. * Sentinel lymph node biopsy (SNB) is a standard staging procedure in early breast cancer. The potentially increasing false negative rate of SNB was concerned if the sonographic abnormal node was not excised. The aim of this study was to evaluate the accuracy of SNB in breast cancer with sonographic abnormal axillary lymph nodes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Wire-localized abnormal node | Before the sentinel lymph node biopsy (SLNB) operation, a hookwire was placed at the suspicious axillary lymph node by ultrasound guidance to localize the abnormal node. In the SLNB operation, radioactive nodes and wire-localized nodes were removed and labeled separately for pathological examination. |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-06-01
- First posted
- 2013-12-09
- Last updated
- 2014-06-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02005926. Inclusion in this directory is not an endorsement.